| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
326,351
|
286,266
|
300,737
|
266,353
| | Cost of Revenue | 228,907 | 209,736 | 216,108 | 187,652 | | |
Gross Profit
|
97,444
|
76,530
|
84,629
|
78,701
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 46,693 | 42,222 | 42,810 | 43,877 |
|
Non Recurring | 16 | 290 | 1,846 | 1,525 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
50,735
|
34,018
|
39,973
|
33,299
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| 1,106 | 1,084 |
-
|
|
Earnings Before Interest And Taxes | 51,372 | 35,124 | 41,057 | 34,463 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 51,372 | 35,124 | 41,057 | 34,463 |
|
Income Tax Expense | 19,658 | 13,341 | 17,303 | 13,987 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 31,714 | 21,783 | 23,754 | 20,476 | |
|
Non-recurring Events |
|
Discontinued Operations | (25) | (467) | (83) | 9 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
31,689
|
21,316
|
23,671
|
20,485
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
31,689
|
21,316
|
23,671
|
20,485
|
|